New diagnostic imaging may make cancer treatment more successful in the future, according to a report from the US.
Doctors at Thomas Jefferson University Hospital have been using a newly-approved imaging agent know as Cysview to greatly improve the detection of bladder cancer.
"We are dedicated to finding new ways to improve the lives of patients living with serious diseases such as cancer and Cysview is the latest example," said Dr Leonard Gomella, associate director for clinical affairs at the Kimmel Cancer Center at Jefferson.
Cysview is used for easier detection of lesions in the patient's bladder that had previously been hard to find.
Dr Gomella believes this new development will help people receive treatment at the early stages of the disease and subsequently save more lives.
Bladder cancer is the seventh most common cancer in the UK and is twice as likely to affect men as women, according to Cancer Research UK.